Central theme of this project is based on detection of exhale breath acetone, bio-marker for diabetes. The exhale breath acetone concentration >2 ppm in breath is considered as diabetic. Accordingly, a gas sensor has been developed based on ternary nanocomposites which can detect trace acetone of exhale breath for monitoring diabetes non-invasively. A handheld, cost effective breath analyzer has been fabricated in our laboratory to measure acetone by analyzing exhale breath. Results are being compared with GC-MS to validate the device.
(a) Fabricated handheld device, and (b) Comparison of device results with GC-MS
Last Updated on January 28, 2021
Dear Sir/Madam,
I am writing this email to express our interest in the non-invasive techniques based on nano-biosensors for diabetes detection that your laboratory has developed. We are impressed with the significant contribution that your laboratory has made in the field of biosensors and are excited about the potential applications of your technology.
We are a research and development firm that focuses on developing innovative healthcare solutions. We believe that your non-invasive techniques based on nano-biosensors for diabetes detection could be a game-changer in the healthcare industry. We would like to explore the possibility of technology transfer from your laboratory and license your technology for commercialization.
We would appreciate it if you could provide us with more information about your technology, including its technical specifications, performance data, and patent status. We would also like to know about the terms and conditions for licensing the technology and the support that you could provide during the technology transfer process.
We are excited about the prospect of collaborating with your laboratory and taking this innovative technology to the market. We look forward to hearing back from you soon and discussing the opportunity further.
Thank you for your time and consideration.
Sincerely